Table 1.

Characteristics of 54 evaluable study subjects

Characteristicsn (%)
Sex
    Men34 (63)
    Women20 (37)
Self-reported race/ethnicity
    White non-Hispanic46 (85)
    Black non-Hispanic4 (7)
    Asian/Pacific Islander2 (4)
    White Hispanic2 (4)
Age (y)57 (29-84)
Body mass index (kg/m2)26 (15-49)
Pretreatment antihypertensive therapy
    None39 (72)
    β-Adrenergic receptor blocker8 (15)
    Calcium channel blocker5 (9)
    Hydrochlorothiazide2 (4)
Tumor type
    Renal carcinoma19 (35)
    Sarcoma13 (24)
    Thyroid carcinoma6 (11)
    Esophageal adenocarcinoma3 (6)
    Non–small cell lung cancer2 (4)
    Neuroendocrine carcinoma2 (4)
    Other*9 (17)
  • *Includes two patients, each with gastrointestinal stromal tumor and melanoma, and 1 patient with breast cancer, thymic carcinoma, hemangioendothelioma, adenoid cystic carcinoma, and nasopharyngeal carcinoma. Note these percentages add to >100 because of rounding.